Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
3(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
6
50%
Ph phase_4
1
8%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Phase 4Post-market surveillance
1(14.3%)
N/ANon-phased studies
6(85.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

12

all time

Status Distribution
Active(4)
Completed(7)
Other(1)

Detailed Status

Completed7
Recruiting3
unknown1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (14.3%)
N/A6 (85.7%)

Trials by Status

completed758%
recruiting325%
unknown18%
not_yet_recruiting18%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
12